SCHEMBL5263590

SCHEMBL5263590

CCCc1nc(N=C(c2ccccc2)c2ccccc2)cnc1Cn1ccnc1-c1cccc(F)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4158181 0.85 — —
SCHEMBL8278166 0.84 — —
SCHEMBL5265789 0.80 ALOX5AP (0.33) —
SCHEMBL5260709 0.80 PDCD1 (0.34) —
SCHEMBL5227829 0.78 GRIN1 (0.32) —
SCHEMBL5266946 0.73 PDE1A (0.31) —
SCHEMBL5886357 0.72 BRD4 (0.33) —
SCHEMBL5266948 0.72 — —
SCHEMBL5780458 0.72 MAPT (0.32) —
SCHEMBL4765982 0.71 ALDH1A1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1619948-A4 SUSTITUTED IMIDAZOLOPYRAZINE AND TRIAZOLOPYRAZINE DERIVATIVES: GABAA RECEPTOR LIGANDS NEUROGEN CORP (US) 2007-02-14 — — EP disclosed
US-20060247245-A1 Substituted imidazolopyrazine and triazolopyrazine derivatives: gabaa receptor ligands NEUROGEN CORPORATION 2006-11-02 — — US disclosed
EP-1619948-A1 SUSTITUTED IMIDAZOLOPYRAZINE AND TRIAZOLOPYRAZINE DERIVATIVES: GABAA RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 2006-02-01 — — EP disclosed
WO-2004107863-A1 SUSTITUTED IMIDAZOLOPYRAZINE AND TRIAZOLOPYRAZINE DERIVATIVES: GABAA RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 2004-12-16 — — WO disclosed
WO-2004107863-A1 SUSTITUTED IMIDAZOLOPYRAZINE AND TRIAZOLOPYRAZINE DERIVATIVES: GABAA RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 2004-12-16 — — WO disclosed
Send feedback